Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people do best weighing themselves once a week on Mounjaro, on the same day, at the same time, under the same conditions. Daily weigh-ins amplify normal fluid shifts that have nothing to do with fat loss, and can make a genuinely effective treatment look like it's failing. That said, the right frequency for you depends on a few factors worth thinking through — and your prescriber's view matters more than any rule of thumb. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber reviews your case, including your progress monitoring, before every dispensing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's completely understandable to want to track every sign of progress when you've just started a new treatment. Mounjaro works gradually, appetite suppression builds over weeks as the dose increases, and the weight loss it produces unfolds over months. That mismatch between impatience and biology is one of the most frustrating parts of early treatment.
The problem with weighing daily is that your body's fluid compartments shift constantly. A salty dinner, a night of poor sleep, the luteal phase of a menstrual cycle, a harder workout than usual, any of these can add a kilogram or two overnight that disappears within 48 hours. If you step on the scale every morning, these fluctuations dominate the readout. You'll see the number go up on days when fat loss is actually continuing, and it's easy to conclude the treatment isn't working.
Weekly readings smooth most of that noise. Choose one morning per week (many people find it easiest to align this with their once-weekly injection day, either just before or just after) and keep every variable the same. Same day, same time, same clothes (or none), same scales, same spot on the floor. Over a month you'll have four data points that tell a coherent story rather than a jagged line that tells several contradictory ones.
The NHS's patient-level guidance on tirzepatide supports a measured approach to monitoring; you can read the NHS overview of tirzepatide for general advice on what to expect during treatment.
Consistency of conditions matters as much as consistency of timing. Body weight is lowest first thing in the morning, after you've used the bathroom and before you've eaten or drunk anything. That's your baseline. Weigh yourself at any other point in the day and you're measuring a different variable.
A few practical details: digital scales are more precise than analogue ones, but precision only helps if the scales are on a firm, flat surface, carpet compresses unevenly and introduces error. Placing them on a bathroom tile or a solid kitchen floor gives a more repeatable result.
Some people find it helpful to record the number somewhere (a note on their phone, a simple spreadsheet) so they can see the direction of travel over 4–6 weeks rather than fixating on any single reading. A plateau of two to three weeks is common after dose increases, as the body adjusts. This is normal physiology, not stalled progress. Understanding how tirzepatide works as a dual GIP and GLP-1 receptor agonist can help make sense of why weight loss isn't linear.
If you're considering cost alongside progress monitoring (thinking about how long you might stay on treatment and what that involves financially) our guide to Mounjaro pricing in the UK sets out what a realistic private treatment budget looks like.
For some people, any frequency of weighing creates more anxiety than information. This is worth naming plainly: the scales are a tool, not a verdict. If stepping on them consistently sends your mood in a direction that makes the rest of the day harder, that's clinically relevant feedback, not a personal failing.
In those situations, monthly weigh-ins (or even relying primarily on how clothes fit and energy levels feel) can be a more sustainable approach. Your prescriber needs some objective measure of progress to review your treatment, but that doesn't have to come from daily home monitoring. A weight recorded at a pharmacy or GP surgery once every four weeks is sufficient for most clinical reviews.
There are also people at the other end of the spectrum who find frequent monitoring genuinely motivating and grounding. If you want a fuller picture of how often you should weigh yourself on Mounjaro, including how to interpret day-to-day swings without losing sight of the longer trend, daily weighing keeps some people engaged without distressing them, so the frequency itself isn't harmful, just interpret individual readings as approximate, and track the weekly average instead of the daily number.
If you're uncertain about the full Mounjaro treatment journey, including what happens at each dose stage, that's exactly the kind of question to raise during a clinical review. Our prescribers cover monitoring, titration and expectations as part of the consultation process.
Weight alone is an incomplete picture, particularly on a treatment like Mounjaro where body composition can shift, muscle mass is preserved better than on very low-calorie diets, but the scales don't distinguish between fat and muscle.
Waist circumference is one of the most clinically useful additional measures: a tape measure around the narrowest point of your waist (roughly level with your belly button, not sucked in) gives you a consistent proxy for visceral fat reduction. NHS guidance treats waist circumference as a meaningful marker of metabolic health, and it often changes before scale weight does.
How you feel physically (energy in the morning, breathlessness on stairs, how much less uncomfortable certain activities are) tells you things the scales can't. Progress that doesn't show up on the scales in a given week frequently shows up here first, and some patients exploring microdosing Mounjaro for inflammation report noticing these physical improvements before any meaningful shift on the scales.
For questions about the wider picture of how treatment is structured, the treatment FAQs cover common monitoring and dosing questions. And if you'd like a prescriber's view on how to track your progress in a way that suits your situation, the best starting point is a free consultation, speak to our prescribers and get a clinical view tailored to you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.